Original article
Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain
Impacto económico del uso de patiromer en enfermedad renal crónica o insuficiencia cardíaca para el tratamiento de la hiperpotasemia crónica en España
Patricia de Sequeraa, Ramón Boverb, Yoana Ivanova-Markovac,
, Alexandra Ivanovac, Almudena González-Domínguezc, Marta Vallsd, Verónica Campose
a Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, Spain
b Servicio de Cardiología, Hospital Universitario Clínico San Carlos, Madrid, Spain
c Departamento de Farmacoeconomía, Weber, Madrid, Spain
d Market Access, CSL Vifor, Barcelona, Spain
e Patient Regional Access, CSL Vifor, Barcelona, Spain
Read
4830
Timeswas read the article
1470
Total PDF
3360
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 11 | 2 | 13 |
| 2025 10 | 187 | 56 | 243 |
| 2025 9 | 293 | 84 | 377 |
| 2025 8 | 173 | 83 | 256 |
| 2025 7 | 202 | 69 | 271 |
| 2025 6 | 178 | 129 | 307 |
| 2025 5 | 142 | 52 | 194 |
| 2025 4 | 79 | 41 | 120 |
| 2025 3 | 125 | 90 | 215 |
| 2025 2 | 75 | 55 | 130 |
| 2025 1 | 75 | 57 | 132 |
| 2024 12 | 57 | 44 | 101 |
| 2024 11 | 68 | 54 | 122 |
| 2024 10 | 63 | 63 | 126 |
| 2024 9 | 64 | 55 | 119 |
| 2024 8 | 67 | 79 | 146 |
| 2024 7 | 51 | 46 | 97 |
| 2024 6 | 54 | 55 | 109 |
| 2024 5 | 70 | 57 | 127 |
| 2024 4 | 100 | 51 | 151 |
| 2024 3 | 77 | 32 | 109 |
| 2024 2 | 79 | 50 | 129 |
| 2024 1 | 1070 | 166 | 1236 |
Show all
